Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Kojonazarov, B. Imanov, M. Kochkorova, M. Mirrakhimov, N. Morrell, M. Wilkins, A. Aldashev (Bishkek, Kyrgyzstan; Cambridge, London, United Kingdom). Endothelin system, exhaled nitric oxide and high altitude pulmonary hypertension. Eur Respir J 2007; 30: Suppl. 51, 3294

Member's Comments

No comment yet.

Related content which might interest you: Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 584s Year: 2003 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction Source: Eur Respir J 2003; 21: 19-24 Year: 2003 Influence of inhaled nitric oxide on plasma endothelin-1 in pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003 Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 Fractional exhaled nitric oxide in pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Infused nitric oxide in experimental pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 348s Year: 2007 Modified exhaled nitric oxide measurement in monocrotaline-exposed rats to monitor pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis Source: Eur Respir J 2004; 24 : 609-614 Year: 2004 The role of nitric oxide in pathogenesis of high altitude pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Role of nitric oxide pathway in pathogenesis of high altitude pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 551s Year: 2007 Increased eNO and pulmonary iNOS expression in eNOS null mice Source: Eur Respir J 2003; 21: 770-773 Year: 2003 Nitric oxide metabolite flux during exercise in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Haemodynamic testing in primary pulmonary hypertension - effects of nitric oxide, iloprost and oxygen Source: Eur Respir J 2001; 18: Suppl. 33, 414s Year: 2001 Replacement of physiologically autoinhaled nitric oxide in intubated patients Source: Eur Respir J 2003; 21: 677-681 Year: 2003 The effect of inhaled nitric oxide on the cardiac performance in patients with hypoxic pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 Exhaled nitric oxide and pulmonary function tests in children with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 759s Year: 2007 Low exhaled nitric oxide in severe uncomplicated obesity Source: Eur Respir J 2006; 28: Suppl. 50, 864s Year: 2006 Acute vasoresponsiveness to inhaled nitric oxide in sarcoidosis-associated pulmonary hypertension Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008 Exhaled nitric oxide in severe obesity Source: Eur Respir J 2004; 24: Suppl. 48, 578s Year: 2004